Evidence map›Paper›PMID 40073224›Full record

ArticleJBRA assisted reproduction2025

Swyer Syndrome: A diagnostic challenge.

Imen Bannour, Badra Bannour, Salma Ferjani, Sassi Boughizane

Abstract readCase Reports
In one paragraph

Article in JBRA assisted reproduction, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Imen BannourDepartment of Gynecology and Obstetrics, University Hospital Farhat Hached, Faculty of Medicine, Ibn Al Jazzar, University of Sousse, Sousse, Tunisia.
Badra BannourDepartment of Gynecology and Obstetrics, University Hospital Farhat Hached, Faculty of Medicine, Ibn Al Jazzar, University of Sousse, Sousse, Tunisia.
Salma FerjaniDepartment of Gynecology and Obstetrics, University Hospital Farhat Hached, Faculty of Medicine, Ibn Al Jazzar, University of Sousse, Sousse, Tunisia.
Sassi BoughizaneDepartment of Gynecology and Obstetrics, University Hospital Farhat Hached, Faculty of Medicine, Ibn Al Jazzar, University of Sousse, Sousse, Tunisia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Swyer syndrome, represents a rare manifestation of primary amenorrhea arising from gonadal dysgenesis. This syndrome is distinguished by the manifestation of a female phenotype despite a 46, XY karyotype. We present the case of a patient aged 32 the second of three sisters; consulted for the first time with a main complaint of primary unexplored amenorrhea responsible for infertility of 1 year with a female phenotype and a male karyotype: 46XY. The laparoscopy performed revealed the presence of a small uterus (an unexpected finding for a feminizing testicular syndrome). The other sisters were respectively examined and found to have the same pathology as their sister and were eventually programmed to have a laparoscopy. 46XY pure gonadal dysgenesis, commonly known as Swyer syndrome, presents as a rare disorder in sexual development. Despite having a 46XY karyotype, affected individuals exhibit a female phenotype. The underlying cause is believed to stem from mutations and deletions affecting the Sex Determining Region Y (SRY) gene located on the short arm of the Y chromosome. Swyer syndrome should be considered in cases of primary amenorrhea with the presence of a uterus. Chromosomal analysis is essential for confirming the diagnosis.

Indexed as

AmenorrheaGonadal Dysgenesis, 46,XYAdultFemaleHumansMale46XYgonadal dysgenesisprimary amenorrheaSwyer syndromeuterus

Identifiers

PMID40073224
PMCPMC11867252

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.